Epidemiological Characterization of Group B Streptococcus Infections in Alberta, Canada: An Update from 2014 to 2020
Angela Ma, L. Alexa Thompson, Thomas Corsiatto, Donna Hurteau, Gregory J. Tyrrell
Abstract
This work describes the epidemiology of invasive infections caused by the bacterium group B Streptococcus (GBS) in Alberta, Canada. We show that rates of invasive GBS disease have increased from 2014 to 2020 for both adult disease and late-onset disease in neonates, whereas the rate of early onset disease in neonates has decreased. We also show that the rate of resistance to erythromycin (an antibiotic used to treat GBS) has also increased in this time.
Topics & Concepts
EpidemiologyClindamycinChemoprophylaxisPenicillinGroup BMedicineErythromycinStreptococcusStreptococcus agalactiaeMicrobiologyPopulationAntibiotic resistanceIncidence (geometry)AntimicrobialDrug resistanceMolecular epidemiologyCumulative incidenceDiseaseTypingBiologyEpidemiological surveillancePublic healthImmunologyInternal medicineGroup APrevalencePregnancyNeonatal and Maternal InfectionsStreptococcal Infections and TreatmentsAntibiotic Resistance in Bacteria